Billings Clinic
Especially For:

Clinical Trials

Title   Breast Cancer: NCCTG N1031 (North Central Cancer Treatment Group)
Description   A Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer

Study also requires that the participating cancer center also offer the N0392 Clinical Trial: Assessment of Patient Satisfaction with Participation iin Phase II/III NCCTG Clinical Trials
IRB Number   NCCTG N1031
Category   Breast Cancer
Inclusion/Notes   Patients must have previous treatment with an anthracycline and/or taxane. Must have had 2 or 3 prior chemotherapy regimens. Patients cannot be HER2 (+).

Additional specific criteria must be met to be able to participate in this clinical trial.
Status   Open to Enrollment
Start Date   06/11/2010
Principal Investigator (PI)   Jorge Nieva, MD
Contact Name   Joan B. Koch, RN
Contact Email
Phone   (406) 435-7481
Alternate Phone   (406) 435-7480
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.